Ruxolitinib in Seborrheic Dermatitis

Clinical trial NCT05787860 · COMPLETED

Trial details

NCT number: NCT05787860
Sponsor: Icahn School of Medicine at Mount Sinai
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Seborrheic Dermatitis

Start date: 2022-11-15
Primary completion: 2024-01-26
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.